Diagnosis of fatty liver disease: Is biopsy necessary?

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 5, 2003, Pages 539-543

  Joy, Diamond ^a   Thava, Vallipuram R ^a   Scott, Brian B ^a  

^a LINCOLN COUNTY HOSPITAL   (United Kingdom)

Author keywords

Computerized tomography; Fatty liver; Hepatic steatosis; Liver biopsy; Magnetic resonance imaging; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Ultrasound scanning

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; EVALUATION; FATTY LIVER; HEPATITIS; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; LIVER BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; STEATOHEPATITIS; STEATOSIS; TECHNIQUE;

BIOPSY; FATTY LIVER; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037726668     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200305000-00014     Document Type: Review

References (40)

1. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50:1844-1850.
2. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow up of forty-two patients for up to 21 years. Hepatology 1990; 11:74-80.
3. Yano E, Tagawa K, Yamaoka K, Mori M. Test validity of periodic liver function tests in a population of Japanese male bank employees. J Clin Epidemiol 2001; 54:945-951.
4. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Japn J Med 1988; 27:142-149.
5. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 2000; 132:112-117.
6. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002; 122:1649-1657.
7. Hilden M, Christofferson P, Juhl E, Dalgaard JB. Liver histology in a 'normal' population - examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol 1997; 12:593-597.
8. Ground KEU. Liver pathology in air crew. Aviat Spac Environ Med 1982; 53:14-18.
9. Luyckx FH, Desaive C, Thiry A, Dewe W, Scheen JE, Gielen JE, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998; 22:222-226.
10. Creutzfeldt W, Frerichs H, Sickinger K. Liver diseases and diabetes mellitus. Prog Liver Dis 1970; 3:371-407.
11. Angulo P, Lindor KD. Treatment of nonalcoholic fatty liver: present and emerging therapies. Semin Liver Dis 2001; 21:81-88.
12. Castera L, Negre I, Samii K, Buffet C. Pain experienced during percutaneous liver biopsy. Hepatology 1999; 30:1529-1530.
13. Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. Gut 1999; 45 (suppl IV):S1-S11.
14. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 1995; 36:437-441.
15. Joseph AEA, Dewbury KC, McGuire PG. Ultrasound in the detection of chronic liver disease (the 'bright' liver). Br J Radiol 1979; 57:23-27.
16. Garra BS, Insana MF, Shawker TH, Russell MA. Quantitative estimation of liver attenuation and echogenicity: normal state versus diffuse liver disease. Radiology 1987; 162:61-67.
17. Needleman L, Kurtz AB, Rifkin MD, Cooper HS, Pasto ME, Goldberg BB. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. Am J Roentgenol 1986; 146:1011-1015.
18. Dewbury KC, Clark B. The accuracy of ultrasound in the detection of cirrhosis of the liver. Br J Radiol 1979; 52:945-948.
19. Taylor JW, Riely CA, Hammers L, Flax F, Weltin G, Garcia-Tsao G, et al. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat. Radiology 1986; 180:65-71.
20. Lin T, Ophir J, Potter G. Correlation of ultrasonic attenuation with pathological fat and fibrosis in liver disease. Ultrasound Med Biol 1988; 14:729-734.
21. Sandford NL, Walsh P, Matis C, Baddeley H, Powell LW. Is ultrasound useful in assessment of diffuse parenchymal liver disease. Gastroenterology 1985; 89:186-191.
22. Graif M, Yanuka M, Baraz M, Blank A, Moshkovitz M, Kessler A, et al. Quantitative estimation of attenuation in ultrasound video images. Invest Radiol 2000; 35:319-324.
23. Foster KJ, Dewbury KC, Griffith AH, Wright R. The accuracy of ultrasound in the detection of fatty infiltration of the liver. Br J Radiol 1980; 53:440-442.
24. Debongnie JC, Pauls C, Fievez M, Wibin E. Prospective evaluation of the diagnostic accuracy of liver ultrasonography. Gut 1981; 22:130-135.
25. Saverymuttu SH, Joseph AEA, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. BMJ 1986; 292:13-15.
26. Joseph AEA, Saverymuttu SH, Al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991; 43:26-31.
27. Skelly M, James PD, Ryder S. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol 2001; 35:195-199.
28. Fagan TJ. Nomogram for Bayes's theorem. N Engl J Med 1975; 293:257.
29. Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 1980; 137:727-729.
30. Bydder GM, Kreel L, Chapman RW, Harry D, Sherlock S, Bassan L. Accuracy of computed tomography in diagnosis of fatty liver. BMJ 1980; 281:1042.
31. Pamilo M, Sotaniemi EA, Suramo I, Lahde S, Arranto AJ. Evaluation of liver steatotic and fibrous content by computerised tomography and ultrasound. Scand J Gastroenterol 1983; 18:743-747.
32. Longo R, Ricci C, Masutti F, Vidimari R, Croce LS, Bercich L, et al. Fatty infiltration of the liver. Quantification by H localized magnetic resonance spectroscopy and comparison with computerised tomography. Invest Radiol 1993; 28:297-302.
33. Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masutti F, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 1997; 27:108-113.
34. Jacobs JE, Birnbaum BA, Shapiro MA, Langlotz CP, Slosman F, Rubesin SE, et al. Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. AJR 1998; 171:659-664.
35. Panicek DM, Giess CS, Schwartz LH. Qualitative assessment of liver for fatty infiltration on contrast-enhanced CT: is muscle a better standard of reference than spleen? J Comput Assist Tomogr 1997; 21:699-705.
36. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984; 153:189-194.
37. Levenson H, Greensite F, Hoefs J, Friloux L, Applegate G, Silva E, et al. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5T vs biopsy. AJR 1991; 156:307-312.
38. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 1994; 12:487-495.
39. Longo R, Pollesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995; 5:281-285.
40. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123:745-750.